Insight Molecular Diagnostics (IMDX) EBT Margin Growth (3y) (2023 - 2026)
Insight Molecular Diagnostics (IMDX) EBT Margin Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -3,107.00 |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 303.00 |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | -485.00 |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 142.00 |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 4,440.00 |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 28.00 |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | -201.00 |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 2,157.00 |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | -226.00 |
| 10 | Insight Molecular Diagnostics | 196.41 Mn | 167.48 Mn | 15,000.00 | -1.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.58 Mn |
| Dec 31, 2025 | 589,077.00 |
| Sep 30, 2025 | -153,580.00 |
| Jun 30, 2025 | -132,447.00 |
| Mar 31, 2025 | 58,015.00 |
| Dec 31, 2024 | 198,471.00 |
| Sep 30, 2024 | -1.03 Mn |
| Jun 30, 2024 | -384,858.00 |
| Mar 31, 2024 | -416,531.00 |
| Dec 31, 2023 | -380,711.00 |
| Sep 30, 2023 | -29,043.00 |
| Jun 30, 2023 | 456,945.00 |
| Mar 31, 2023 | 5.72 Mn |